Executive to join company on September 1.
After serving as CEO for Zimmer Biomet since 2017, Bryan Hanson has been appointed as the new CEO of 3M’s Health Care Business Group. Expected to take the reins when the independent health care company is spun off from 3M, Hanson will officially join the organization on September 1.
As a separate entity, 3M believes that Health Care Business Group will be better positioned to deliver industry-leading innovation that enables better, smarter, and safer healthcare for patients worldwide.
“We are pleased to have Bryan join us to advance the spin-off of our Health Care business and build a leading independent medical technology innovation company,” said Mike Roman, 3M chairman, CEO. “His industry expertise, ability to drive growth, and track record of building a strong culture and teams will make an immediate impact.”
Reference: Bryan Hanson Named CEO of 3M’s Health Care Business Group. 3M. August 22, 2023. Accessed August 23, 2023. https://news.3m.com/Bryan-Hanson-Named-CEO-of-3Ms-Health-Care-Business-Group
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.